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Abstract 
 
A key issue for the fabrication of scaffolds for tissue engineering is the development of 
processing techniques flexible enough to produce materials with a wide spectrum of 
solubility (bioresorption rates) and mechanical properties matching those of calcified 
tissues. These techniques must also have the capability of generating adequate porosity 
to further serve as a framework for cell penetration, new bone formation, and subse-
quent remodeling. In this study, we show how hybrid organic/inorganic scaffolds with 
controlled microstructures can be built using robotic assisted deposition at room tem-
perature. Polylactide or polycaprolactone scaffolds with pore sizes ranging between 
200–500 μm and hydroxyapatite contents up to 70 wt % were fabricated. Compressive 
tests revealed an anisotropic behavior of the scaffolds, strongly dependent on their 
chemical composition. The inclusion of an inorganic component increased their stiffness 
but they were not brittle and could be easily machined even for ceramic contents up 
to 70 wt %. The mechanical properties of hybrid scaffolds did not degrade significantly 
after 20 days in simulated body fluid. However, the stiffness of pure polylactide scaf-
folds increased drastically due to polymer densification. Scaffolds containing bioactive 
glasses were also printed. After 20 days in simulated body fluid they developed an 
apatite layer on their surface. 
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INTRODUCTION 
 
The demand for biomaterials to assist or replace organ functions and improve quality 
of life is rapidly increasing.1 Traditional biomaterials for bone replacement are devel-
oped from materials designed originally for engineering applications that have serious 
shortcomings associated to the fact that their physical properties do not match those 
of the surrounding tissue and, unlike natural bone, cannot self‐repair or adapt to chang-
ing physiological conditions. Thus, an ideal solution, and a scientific research challenge, 
is to develop bone‐like biomaterials (or tissue engineering scaffolds) that will be treated 
by the host as normal tissue matrices and will integrate with bone tissue while they 
are actively resorbed or remodeled in a programmed way, with controlled osteogenic 
activity. This material will require an interconnected pore network with tailored surface 
chemistry for cell growth and penetration, and the transport of nutrients and metabolic 
waste. It should degrade at a controlled rate matching the tissue repair rates producing 
only metabolically acceptable substances and releasing drugs or stimulating the growth 
of new bone tissue at the fracture site by slowly releasing bone growth factors (e.g., 
bone morphogenic protein or transforming growth factor‐β) throughout its degradation 
process. In addition, its mechanical properties should match those of the host tissues 
and the strength and stability of the material–tissue interface should be maintained 
while the material is resorbed or remodeled. 
 
In recent years, there has been an increasing interest in the fabrication of porous three‐
dimensional structures with complex functionalities not only for use in tissue engineer-
ing but also for many other applications such energy generation, structural, electronics, 
etc. Techniques such as solvent casting, particulate leaching, gas foaming, etc.2-5 have 
been traditionally used for synthesizing porous structures, but they suffer from numer-
ous drawbacks including need for specialized tooling and molds, poor reproducibility, 
lack of proper control of porosity and interconnectivity, and, consequently, poor, un-
predictable mechanical properties. This has been one of the motivations behind the 
development of new solid freeform fabrication techniques such as direct ink‐jet printing, 
robotic assisted deposition or robocasting, and hot‐melt printing, which usually involve 
“building” structures layer‐by‐layer by deposition of colloidal inks following a computer 
design; this can be achieved with great precision and reproducibility.6-11 
 
One of the techniques that is gaining popularity during the last few years is ro-
bocasting12, 13 where computer‐controlled deposition of a thick slurry is performed to 
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form three‐dimensional structures layer‐wise at room temperature. Until now, ro-
bocasting has been used to print ceramic inks where consolidation of the structures is 
achieved through a fluid through‐gel transition during printing.14 One of the great 
challenges is to develop the right inks or suspensions to print materials with a wider 
range of chemistries with precision and reproducibility. In this work, we demonstrate 
how this technique can be used to build three‐dimensional organic/inorganic hybrid 
structures with controlled porosity, custom compositions, and appealing mechanical 
properties. The inorganic component of the materials is either hydroxyapatite (HA), 
an osteoconductive calcium phosphate closely related to the inorganic component of 
bone, or a bioactive silica‐based glass. Since the formulation of the first bioactive glasses 
by Hench, they have been extensively used in the fabrication of biomaterials and com-
posites due to their capacity to generate hydroxyapatite and form excellent bond with 
osseous tissue.15 For the organic component we have chosen either polylactide (PLA) 
or polycaprolactone (PCL), two biocompatible and fully resorbable polymers with dif-
ferent stiffness, approved by the Food and Drug Administration (FDA) for medical 
applications. The work describes the development of hybrid inks for the fabrication of 
porous scaffolds by robotic assisted deposition and analyzes the physicochemical factors 
that control their final properties, in particular their in vitro evolution in simulated 
body fluid. 
 
MATERIALS AND METHODS 
 
Scaffolds fabrication 
 
The inorganic component of the hybrid inks was either commercially available HA 
powders (Trans‐tech Adamstown, MD, USA) with a particle size between 1 and 3 μm 
[Fig. 1(a)], Bioglass® with the composition 45S5 developed by Hench or a high‐silica 
bioactive glass originally developed in our laboratory for the fabrication of coatings on 
metallic alloys (6P53B)16 (Table I). The glass powders have a wide particle size dis-
tribution with an average of ∼13 ± 2 μm16 [Fig. 1(b)]. Properties of the different mate-
rials used (density, Young's modulus, and compressive strength) are given in Table II. 
 
 4 
 
Figure 1: Scanning electron micrograph of (a) hydroxyapatite powders and (b) 6P53B 
glass powders used in this work. 
 
Table I. 6P53B and Bioglass Compositions in Weight and mol %. Values in parentheses 
are in mol %. 
 SiO2  Na2O  K2O  CaO  MgO  P2O5 
6P53B 52.7 (51.9)  10.3 (9.8)  2.8 (1.8)  18.0 (19.0)  10.2 (15.0)  6.0 (2.5) 
Bioglass 45 (46.1)  24.5 (24.3)  0.0 (0.0)  24.5 (26.9)  0.0 (0.0)  6.0 (2.6) 
 
     
Table II. Density, Young's Modulus, and Compressive Strength of the Raw Materials 
 Density (g/cm3)  Young Modulus (GPa)  Compressive Strength (MPa) 
PLA   1.24   2.717     40–120 (pellet)18 
PCL   1.14   0.417     – 
Sintered 3.16   35–12019    120–90019 
dense HA 
Bioglass®  2.7   35     ∼50018 
6P53 B  2.716   7020     ∼7021 
 
Two different polymers were used in the inks: polylactide (PLA) (molecular weight = 
92.1 kg/mol, 86.4% L isomer) and polycaprolactone (PCL) (Sigma Aldrich, Saint‐Louis, 
MO, USA, molecular weight = 80 kg/mol). To prepare the inks, 5 g of polymer (PLA 
or PCL) were dissolved in 15 mL of methylene chloride (J.T. Baker, Phillipsburg, NJ, 
USA) at room temperature for 2 h using a magnetic stirrer. The required amount of 
HA or glass was added to the solution, together with 5 mL of denatured ethanol (water 
content <0.1%) to control the viscosity of the slurry and the evaporation kinetics and 
homogenized in a ball mill with alumina balls for 1 h. The final quality of the ink was 
assessed in terms of printability‐measured as the minimum tip diameter suitable to 
extrude the ink without clogging and stability (i.e., shape retention capacity during 
drying and sintering) of the assembled structures. 
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Porous scaffolds were printed with a robocasting machine (3D inks, Stillwater, OK, 
USA) whose 3‐axis motion was independently controlled by a custom‐designed, com-
puter aided direct‐write program (Robocad 3.0, 3D inks, Stillwater, OK, USA). The 
deposition process was carried out in ambient atmosphere at room temperature. The 
three‐dimensional periodic scaffolds (∼15 × 15 mm2 in length and ∼4 mm in height 
corresponding to 17 layers) consisted of a linear array of parallel rods in each layer 
aligned such that their orientation was orthogonal to the previous layer [Fig. 2(a)]. The 
center‐to‐center rod spacing was varied between 0.5 and 1 mm in order to change the 
porosity of the samples. Once a layer was printed, the nozzle was raised by a fixed 
height, which depends on the tip diameter, and another layer was deposited. The di-
ameter of the printing nozzles was varied from 5 to 410 μm and the printing speed 
between 5 and 20 mm/s. During printing, the flow rate was adjusted to the nozzle 
diameter and the printing speed [Eq. (1)] in order to print a continuous line of uniform 
thickness: 
𝑉$ =
𝜑&
𝜑'
2
𝑉) 
where Vp is the speed of the piston, ϕt is the diameter of the tip, ϕs is the diameter of 
the syringe, and Vw is the printing speed. Samples were printed on glass slides and were 
easily removed after drying overnight at room temperature in air. 
 
 
Figure 2: (a) Schematic representation of the robocasting process. The syringe displace-
ment and the liquid flow through the nozzle are controlled by the computer. (b) During 
the printing, the inks swell after leaving the capillaries and the evaporation of the 
solvent creates a solid skin favoring the consolidation of the printed line. (c) Low mag-
nification picture showing one of the scaffolds fabricates in this study (HA/PLA, 70 wt 
% HA scaffold with 17 layers). (d) Three-dimensional reconstructed image of a 
HA/PLA (70 wt % HA) grid obtained by synchrotron X‐ray computed tomography. It 
can be observed that the material does not exhibit large defects 
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Physical, microstructural, and mechanical characterization 
 
The average porosity was calculated using the measured diameter of the printed rods 
and their spacing. The microstructure and composition of the printed parts were ana-
lyzed by X‐ray diffraction (D500 diffractometer, Siemens AG, Munich, Germany), op-
tical microscopy (Axiotech microscope, Carl Zeiss AG, Oberkochen, Germany), and 
environmental‐scanning electron microscopy (ESEM: S‐4300SE/N, Hitachi, USA) with 
associated energy dispersive spectroscopy (EDS). To obtain a three‐dimensional per-
spective of the structure, particularly to reveal subsurface defects, synchrotron X‐ray 
computed tomography was performed at the Advanced Light Source (ALS, Berkeley, 
CA). Imaging was achieved on representative structures with 26 keV monochromatic 
X‐rays and a 6 μm voxel size (resolution). The tomography data were reconstructed 
into three‐dimensional images by a Fourier‐filtered back‐projection algorithm as de-
scribed in detail elsewhere.22 
 
The Vickers micro hardness of the printed lines was measured by placing at least five 
indentations on 6 μm polished surfaces with a load of 30 g. Compression tests of 
strength, in the direction parallel and perpendicular to the printing plane, were carried 
out on a ELF® 3200 series voice‐coil mechanical testing machine (EnduraTEC Inc., 
Minnetonka, MN) with a crosshead speed of 0.2 mm/min on pieces (4 × 3 × 3 mm3) 
cut with a blade from the printed scaffolds. At least four tests were performed for each 
composition and each direction. 
 
The in vitro response of the scaffolds was studied by immersing the samples in 30 mL 
of simulated body fluid (Table III) at 37°C for 20 days. The solution was prepared by 
dissolving reagent‐grade chemicals of NaCl, NaHCO3, KCl, K2HPO4, MgCl2.6H2O, 
CaCl2, and (CH2OH)3CNH2 into distilled water and buffered with HCl to pH 7.25 at 
37°C.23 The evolution of the pH in the solution was measured with a pH meter (model 
3000, VWR Scientific). After 20 days of immersion, the samples were washed with large 
amounts of distilled water and air dried prior to microstructural and mechanical char-
acterization. 
 
Table III. Ion Concentrations of the SBF used in this Work and of Human Plasma 
 Ion Concentration (mM) 
Na+  K+  Ca2+  Mg2+  Cl−  HCO3-  HPO42-  SO42- 
SBF    142.0  5.0  2.5  1.5  147.8  4.2   1.0   0.5 
Human plasma  142.0  5.0  2.5  1.5  103.0  27.0   1.0   0.5 
 
Thermal properties of PLA (in as received conditions, after 20 days at 37°C in air and 
after 20 days at 37°C in SBF) were determined using a differential scanning calorimeter 
(DSC). The measurements were run under Neon/Helium 50/50 volume mixture gas at 
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a heating rate of 100°C/min using a Perkin Elmer Diamond DSC calibrated with in-
dium. The typical sample weight was 1 mg. There was no thermal treatment of the 
samples before the first heating scan in order to preserve their history. The reported 
glass transition temperatures (Tg) were taken as the mid‐point of the step transition 
based on first heating scans from 25 to 150°C. 
 
RESULTS AND DISCUSSION 
 
Physical and microstructural characterization of the printed 
samples 
 
The process used in the preparation of the inks is based on the dissolution of the 
polymers in methylene chloride, like the standard procedure used for the preparation 
of biodegradable polymer and HA/polymer microspheres for drug delivery and compo-
site fabrication.24, 25 The two key differences are that no polyvinyl alcohol or any other 
difficult to eliminate and potentially toxic surfactants are used and that small quanti-
ties of a second organic phase (ethanol) are added in order to tailor the ink viscosity 
and drying rates to the printing conditions. During printing, solvent evaporation cre-
ates a solid skin on the extruded line immediately after it exits the tip [Fig. 2(b)]. This 
skin confers some degree of rigidity to the printed line and allows the fabrication of 
stable three‐dimensional structures [Figs. 2(c,d)]. Consolidation of the lines is achieved 
by matching the printing speeds to the drying kinetics of the ink. For very slow printing 
speeds (typically less than 5 mm/s), the paste will dry up in the printing nozzle, thus 
clogging it; if the printing speed is too fast (faster than 20 mm/s), the line diameter is 
not homogeneous and the lines can be discontinuous. 
 
The printing behavior of the inks also depends on their inorganic content. High particle 
loads can result in large viscosities and poor printability. However, by adjusting the 
amount of ethanol (the amount of ethanol vs. inorganics, i.e., ceramic powders, is ∼40 
wt %) it is possible to prepare hybrid scaffolds with inorganic contents as large as 70 
wt %, very close to the mineral content of cortical bone. This is very important since 
the ceramic content influences the stiffness, a key mechanical parameter that should 
be matched with the host tissue. Typical required Young's modulus (E) varies between 
0.4 and 350 MPa for soft tissue and cartilage and up to 10–1500 MPa for hard tissue.6 
Particular attention should be paid to the control of the evaporation of the organic 
component during ink preparation. Because of the use of methylene chloride as a sol-
vent, drying is quite rapid and the ink properties need to be maintained in the range 
adequate for printing by hermetically sealing the containers. However, because the 
main mechanism of consolidation is drying, control of the rheological properties does 
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not need to be as strict as for ceramic inks.13 Furthermore, during robocasting of ce-
ramic parts different strategies (such as printing in oil baths) are used to avoid drying 
and the associated dimensional changes and stresses during printing.26 In the process 
described in this work, the viscoplastic behavior of the parts allows them to sustain 
the stresses generated during simultaneous printing and drying. This viscoplastic na-
ture permits further stretching of the printed line to form thin polymer and polymer/ce-
ramic fibers and ribbons (down to 1 μm in diameter). Figure 3 shows very thin polymer 
and hybrid threads fabricated in this manner. It can be clearly observed that the min-
imum achievable diameter of the thread is controlled by the size of ceramic particles. 
Biodegradable fibers can be used in drug delivery applications or in the fabrication of 
meshes for implants and scaffolds.27 
 
 
Figure 3: (a) Pure PLA flexible ribbon and (b) thin HA/PLA (30/70 wt %) thread 
extruded after printing. Hydroxyapatite grains are embedded in the polymer fiber and 
determine its minimum diameter. 
 
It was not possible to successfully prepare an ink containing the Bioglass composition 
developed by Hench. This is attributed to the highly hygroscopic nature of this glass 
(related to its high bioactivity) that promotes fast reactions with small amounts of 
water in the environment or in the ink. This fact also hampers the use of Bioglass in 
the preparation of suspensions to coat metallic alloys by enameling28 and motivated 
the development of a family of high‐silica bioactive glasses like 6P53B that are much 
less hygroscopic and more amenable to the preparation of suspensions. Although sev-
eral techniques have been proposed to prepare Bioglass/polymer foams and porous 
materials18, 29, 30 by using the 6P53B composition, it was possible to prepare hybrid inks 
optimized for rapid prototyping. 
 
Partial wetting of the ink on the printed material increases the contact area and pro-
vides better bonding between lines [Fig. 4(a)], enhancing the stability of the structure. 
In the hybrid scaffolds the ceramic phase is homogeneously distributed in the polymer 
[Fig. 4(b)] and there are no visible surface defects or microporosity. By changing the 
center‐to‐center rod spacing (0.5 and 1 mm), samples with 2 different porosities are 
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processed. A center‐to‐center rod spacing of 0.5 mm corresponds to a porosity of 55% 
and a pore size of about 200 µm [Fig. 4(c)], while a center‐to‐center rod spacing of 1 
mm gives a porosity of 75% and a pore size of about 500 µm [Fig. 4(d)]. 
 
 
Figure 4: Scanning electron micrographs showing different aspects of the microstruc-
ture. All the scaffolds showed in this picture have been printed using a nozzle with an 
internal diameter of 410 μm. (a) Three-dimensional reconstructed image of the junction 
between HA/PLA (70 wt % HA) printed lines obtained by synchrotron X‐ray com-
puted tomography. It can be observed that the ink wets partially the printed lines 
providing additional support and leading to good bonding between lines (white circles). 
(b) Close up of an HA/PLA (70 wt % HA) printed line showing the homogeneous 
distribution of the HA particles (white) in the polymer. (c) HA/PCL (70 wt % HA) 
scaffold (center‐to‐center rod spacing ∼0.5 mm, corresponding to a porosity of ∼55%); 
the pore size and thickness of the printed lines is very homogeneous. (d) 6P53B 
glass/PLA (70 wt % 6P53B glass) scaffold (center‐to‐center rod spacing ∼1 mm, corre-
sponding to a porosity of ∼75%). 
 
The final line thickness depends on several factors: nozzle diameter, printing speed, 
printing height [ΔZ in Fig. 2(b)], and drying shrinkage (typically ∼25% in volume). 
After leaving the nozzle, the ink was observed to swell, with the degree of swelling 
depending on the printing speed (flow rate) and the nozzle diameter. As shown in 
Figure 5, for a 410‐μm tip, the swelling and the printing speed influence are minimal 
and the drying shrinkage is important since the final average line diameter is around 
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200 μm. For a very thin capillary of 5 μm, there is a significant swelling that can be 
controlled by increasing the printing speed and the diameter of the printed lines can 
be reduced from 400 to 100 μm, without affecting the pore size, by changing the print-
ing speed from 5 to 20 mm/s. 
 
 
Figure 5: Evolution of the final line diameter versus the printing speed for the printing 
of a pure PLA ink through nozzles with two internal diameters. The insert shows a 
scanning electron micrograph of a PLA grid printed with a 5‐μm tip at a printing speed 
of 15 mm/s. 
 
In a further step, the scaffolds can be infiltrated to make dense samples with controlled 
composition and phase distributions. By using phases with different degradation rates 
porosity can be created “in situ” providing interesting possibilities for the control of 
the bioresoption and the mechanical behavior in vivo. For example, we have been able 
to successfully infiltrate a PLA/HA (70 wt % of HA) scaffold with a PCL/HA slurry 
(70 wt % of HA, with a slurry prepared exactly in the same conditions than the inks 
for printing) under vacuum (150 mbar) without leaving residual porosity (Fig. 6). The 
systematic analysis of the microstructure and properties of these materials will be the 
subject of a future work. 
 
 11 
 
Figure 6: Scanning electron micrograph of a PLA/HA (70 wt % HA) scaffold cross 
section infiltrated with PCL/HA (70 wt % HA). No residual porosity can be observed 
after the infiltration process. 
 
In vitro behavior in simulated body fluid 
 
In vitro tests in cell‐free solutions with ionic concentrations similar to those of body 
fluids allows analysis of the chemical and microstructural evolution of the materials 
under conditions that simulate their biological interactions with the body and provide 
fundamental data to predict and understand their in vivo behavior and long term 
stability.23 After 20 days in simulated body fluid microporosity develops on the surface 
of pure PLA scaffolds (pore size from 0.5 to 1 μm) (Fig. 7). To analyze the possible 
changes in the polymer structure induced by the in vitro treatment at 37°C, DSC 
analysis of the “as received” PLA and after 20 days at 37°C in air and in SBF are 
performed (Fig. 8). The DSC analysis confirms that, as expected, the as received PLA 
is amorphous since it contains 14% of D isomer. However, its glass transition temper-
ature increases from 33.0°C for the as received materials to 49.1°C after 20 days at 
37°C or to 60.8°C after 20 days at 37°C in SBF. These results indicate that the struc-
ture of the polymer is changing during the in vitro tests: the polymer chains are organ-
izing and the polymer is getting denser. This temperature and humidity are two factors 
responsible for the densification of the PLA. No diffusion of SBF ions into the polymer 
is observed by EDS analyses. The volume change associated with the densification 
might be responsible for the formation of the micropores. The addition of HA to the 
PLA reduces significantly the shrinkage of the material and micron size pores do not 
form on HA/PLA scaffolds even after 20 days in SBF. Degradation of the PCL‐based 
scaffolds (with or without hydroxyapatite) results in the formation of a network of 
polymer fibers between the printed lines (Fig. 9) while their surface becomes rougher. 
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Figure 7: (a) Scanning electron micrographs of a PLA scaffold after 20 days in SBF. 
Note the presence of micron size pores homogeneously dispersed on the polymer surface. 
(b) The inset shows these pores at a larger magnification. 
 
 
Figure 8: Evolution of the glass transition temperature and stiffness up to the elastic 
limit for PLA scaffolds in an as received condition, after 20 days at 37°C in air and 
after 20 days at 37°C in simulated body fluid. 
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Figure 9: Scanning electron micrograph of a PCL/HA (70 wt % HA) scaffold after 20 
days in SBF. Polymer filaments are bridging the lines. The degradation of the scaffold 
surface is clearly visible. 
 
The formation of acidic products during the hydrolytic degradation of resorbable pol-
ymer materials has been reported to cause adverse body reactions and additions of 
various calcium phosphates to the polymer have been proposed as a mean to buffer the 
release of acidic products and avoid these reactions.31-34 Figure 10 shows the pH evolu-
tion of the simulated body fluid solution in which the PLA‐based samples were im-
mersed. The behavior is similar for PCL based scaffolds. The pH remains stable, around 
7.25, for pure polymer and HA/polymer composites. The presence of glass particles has 
two effects: the pH of the solution increases to reach 7.8 after 20 days of immersion for 
scaffolds containing 6P53B glass and apatite crystals precipitate on the scaffold surface 
(Fig. 11). This is due to a rapid ion exchange of Na+ from the glass with H+ and 
H3O+ followed by a polycondensation reaction of surface silanols to create a high‐
surface area silica gel. This gel can provide a large number of sites for heterogeneous 
nucleation and crystallization of a biologically reactive hydroxy‐carbonate apatite 
(HCA) layer equivalent to the inorganic mineral phase of bone.15 The ion exchange 
from the bioactive glass can buffer the acidic products resulting from polymer degra-
dation and promote apatite precipitation. It has been proposed that this growing apa-
tite layer favors the bonding to bone of bioactive glasses and has a significant impact 
on the activity of osteogenic cells.35 
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Figure 10: pH evolution of the solution during 20 days of immersion in SBF for PLA, 
PLA/HA, and PLA/6P53B glass materials. Note the increase in pH for the 6P53B 
glass/PLA scaffold. 
 
 
Figure 11: Scanning electron micrographs of the 6P53B glass/PLA scaffold after 20 
days of immersion in SBF. (a) Apatite crystals have precipitated on the scaffold sur-
face. (b) The apatite layers consist of small nano‐crystals (inferior to 50 nm) that cover 
progressively the scaffold. 
 
Mechanical characterization 
 
Microhardness 
 
As expected from the intrinsic properties of the polymers (Table II) the printed lines 
of the PLA‐based scaffolds are much harder than the equivalent PCL composites 
(Fig. 12). The hardness of the glass is 6.2 GPa.16 There is a wide spread in the hardness 
data reported for sintered HA but it seems to range between 3.5 and 6.5 GPa for a 
fully dense ceramic.36-38 The addition of glass increases the hardness but there is a larger 
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dispersion in the measurements probably due to the larger grain size and the larger 
dispersion of the grain size distribution. After immersion in simulated body fluid the 
hardness of pure PLA and PLA/HA materials increase slightly. This might be due to 
the observed densification of the polylactide during the in vitro tests. 
 
 
Figure 12: Micro hardness of the printed lines samples in as received conditions and 
after 20 days in a SBF. Organic/inorganic samples have 70 wt % of inorganic phase. 
 
Compression strengths 
 
Compression tests are performed in two directions (Fig. 13), perpendicular (direction 
1) and parallel (direction 2) to the printing plane. During the tests, the scaffolds do 
not fail in a brittle manner and show an elasto‐plastic response with large plastic 
“yielding”. The insets on Figure 13 show SEM pictures of the samples in both directions 
after compression. Only PLA/HA samples tested in the direction 2 show a maximum 
in the stress vs. strain curve at around 7–10 MPa. This is probably due to the fact that 
they are harder and stiffer and the printed lines buckle instead of being continuously 
deformed like in the other scaffolds (Fig. 13). 
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Figure 13: Strain–stress curves obtained from compression tests made on different grids 
of HA/PLA (70 wt % HA) samples with 55% of porosity in the two directions (a) 
perpendicular (direction 1) and (b) parallel (direction 2) to the printing plane. The 
insets show some SEM images of the samples after compression tests in direction 1 and 
2. The stress–strain curves in each direction are very similar. The samples do not fail 
in a brittle manner and the behavior is anisotropic. Buckling of the printed lines of the 
PLA/HA scaffolds can be clearly observed in the inset [Fig. 13(b)]. 
 
The lines do not debond during testing in any direction, indicating excellent adhesion 
between the printed rods. The stress–strain curves for samples with the same compo-
sition and microsctructure are very similar (Fig. 13), allowing the comparison of the 
mechanical response of different materials. Considering the samples' geometry and due 
to their large deformation, it is difficult to calculate an absolute value of the Young's 
modulus from the compression tests. However, the slope of the compression curves 
(calculated using a linear fit of the data up to the elastic limit) can provide several 
trends. 
1. The porosity (in the range used in this work, between 55 and 75 vol %) does not 
affect significantly the mechanical response of the samples. 
2. The mechanical response of the scaffolds is clearly anisotropic (Fig. 13). 
3. The mechanical properties can be easily adjusted by controlling the composition 
of the material: type of polymer and inorganic content. Addition of up to 70 wt 
% of hydroxyapatite increases the stiffness up to two orders of magnitude [Fig. 
14(a)] and PLA‐based scaffolds are much stiffer than those containing PCL [Fig. 
14(b)]. For an HA/polymer scaffolds with a porosity of 55% (pore size ∼200 × 
200 μm2) and an HA content of 70 wt %, the values of the slopes in the direction 
perpendicular to the printing plane varies between 84 ± 9 MPa for a PLA‐based 
materials and 24 ± 5 MPa for PCL‐based materials. In the parallel direction, 
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the slopes vary between 150 ± 40 and 110 ± 20 MPa for PLA and PCL‐based 
scaffolds, respectively. This is expected since the elastic modulus of dense PLA 
and PCL are respectively 2.7 and 0.4 GPa (Table II). 
4. After twenty days in SBF, pure PLA scaffolds become much stiffer and the slope 
of the strain–stress curve up to the elastic limit increases from 3 ± 2 to 76 ± 19 
MPa [Fig. 15(a)]. Like the parallel increase in microhardness, this is related to 
the observed densification of the polymer as a result of the in vitro treatment. 
The PLA scaffolds also become stiffer after 20 days in air at 37°C. The slope's 
average value of their strain–stress curve up to the elastic limit is 35 ± 6 MPa. 
As it is confirmed by the DSC analysis, the long treatment at 37°C promotes 
densification and this process is enhanced in SBF (Fig. 8). The moisture plasti-
cizes the polymer chains favoring their rearrangement and enhancing densifica-
tion. This result suggests that thermal treatments can be used to further manip-
ulate the mechanical response of the material. 
5. The compressive behavior of the PLA or PCL‐based hybrid scaffolds containing 
70 wt % of hydroxyapatite do not change significantly after 20 days in simulated 
body fluid. The elastic modulus of HA is 10–100 times larger than the one of the 
polymer (Table II) and the main contribution to the Young's modulus of the 
composites comes from the inorganic phase that does not undergo any visible 
degradation during in vitro testing in SBF. However, the bioactive glasses react 
with simulated body fluid and there is an appreciable decrease of the stiffness in 
the scaffolds containing 6P53B after 20 days in SBF [Fig. 15(b)]. 
 
 
Figure 14: (a) Influence of the ceramic content on the compressive behavior of the 
scaffolds. The strain–stress curves are obtained from compression tests made on PLA 
and HA/PLA samples in two directions. Addition of hydroxyapatite increases signifi-
cantly the stiffness of the material. (b) Influence of the organic phase. Samples con-
taining PLA are stiffer. 
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Figure 15: (a) Strain–stress curves obtained from compression tests made on pure PLA 
samples in the direction 1. The sample has become stiffer after in vitro testing in SBF. 
(b) Strain–stress curves obtained from compression tests made on 6P53B glass/PLA 
(70 wt % 6P53B glass) samples in the direction 1. Before immersion, 6P53B glass/PLA 
composites have a slope's average value of their strain–stress curve up to the elastic 
limit of 105 ± 18 MPa. This value is comparable with the one of the as received 
HA/PLA in direction 1. After 20 days in a physiological environment, the slope's av-
erage value of the composites with bioactive glass decreases to 62 ± 10 MPa (∼40% 
reduction) due to a partial dissolution of the glass in the solution before the formation 
of apatite crystals at the surface of the scaffold. 
 
SUMMARY 
 
This work demonstrates how robotic assisted deposition can be successfully used for 
the fabrication of porous hybrid organic/inorganic materials of various chemical com-
positions with well controlled architecture and porosity. The technique is versatile 
enough to allow the combination of a wide range of materials, including bioactive 
glasses whose addition can be used to buffer the possible formation of acidic degrada-
tion product coming from the hydrolytic degradation of the polymer and to promote 
apatite formation. In addition, by selecting the adequate organic component and ma-
nipulating the organic/inorganic ratio of the scaffolds, we can control their stiffness 
and fabricate materials much more rigid than porous polymers while avoiding the brit-
tleness of ceramic parts. Moreover, multi‐component materials can be fabricated 
through the simultaneous use of multiple nozzles and because the processing is per-
formed at room temperature, in situ seeding with cells and addition of drugs or growth 
factors to the organic component is easily achievable. These characteristics suggest that 
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robotic assisted deposition can be a fast and economical alternative for the fabrication 
of “on demand” scaffolds for biomedical applications. 
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